A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

Title
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 16, Issue 4, Pages 1256-1263
Publisher
American Association for Cancer Research (AACR)
Online
2010-02-10
DOI
10.1158/1078-0432.ccr-09-1267

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More